HIV and Hepatitis B Coinfection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HIV and Hepatitis B Coinfection trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06264583

HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection

The aim of this project is to set up a cross-sectional cohort study (France, Germany, The Netherlands, Poland, Spain, Switzerland, Italy, United Kingdom and Por…

Germany8,000 participantsStarted 2024-05-01

Treatment: HDV screening

All recent trials (19 shown)

CompletedNot Applicable

NCT01350648

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

Background: \- Hepatitis B and hepatitis C can cause liver damage. They can also cause serious illness, including liver cancer, and even death. This study will…

United States569 participantsStarted 2011-08-23

By InvitationNot Applicable

NCT02699736

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

The EuroSIDA study is a prospective observational cohort study of 23,000+ patients followed in 100+ clinics in 35 European countries, Israel and Argentina. The…

Argentina, Austria, Belarus23,000 participantsStarted 1994-01

CompletedPhase 4

NCT03797014

HIV and Hepatitis B Coinfection

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection

All recent trials (19 shown)

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection

All recent trials (19 shown)

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

B/F/TAF Switch Study for HIV-HBV Coinfection

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

TAF for HIV-HBV With Renal Dysfunction

Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patien…

Hepatitis B and HIV Co-Infection in Patients in Uganda

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfection

Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults

A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection

Tenofovir in HIV/HBV Coinfection

Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infe…

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected…

Long-term Effectiveness and Safety in Hepatitis-co-infected Patients

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Te…

HIV-HBV Co-Infection and Liver Disease

Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV c…